Magnifying glass with pills on blue
Pharma

Regulatory tracker: Viatris' Ryzumvi lands FDA presbyopia nod

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Podcast
The Next Chapter for AI in Clinical Trials

The Next Chapter for AI in Clinical Trials

Brought to you by Saama
CDMO Samsung Bio wins temporary reprieve from strike threat after Seoul court ruling

Samsung Bio blunts impact of strike threat with court ruling

Oct 20, 2026 1:40pm
Why Are 53 of Phase 2 and 3 Trials Delayed A Redesign Is Overdue

Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue

Brought to you by Bain & Company
North America on a globe

Antheia, DOD shake on $80M manufacturing loan

Oct 20, 2026 11:35am
Stamp with blue ink that says FDA Approved

Cosette lands FDA approval for Evoxac liquid in Sjögren’s

Oct 20, 2026 11:22am
More News

AbbVie hits the gas on immunology awareness with McLaren F1 pact

Oct 20, 2026 10:30am

Veradermics ph. 3 win backs up its stellar stock performance

Oct 20, 2026 10:10am

Amgen, AZ eye Tezspire expansion after detailed EoE ph. 3 win

Oct 20, 2026 9:00am
Fierce Biotech

AstraZeneca taps Oracle to improve recruitment for trials

Oct 20, 2026 2:36am